BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21087344)

  • 1. The radiosensitization effect of NS398 on esophageal cancer stem cell-like radioresistant cells.
    Che SM; Zhang XZ; Liu XL; Chen X; Hou L
    Dis Esophagus; 2011 May; 24(4):265-73. PubMed ID: 21087344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 inhibitor NS398 enhances radiosensitivity of radioresistant esophageal cancer cells by inhibiting AKT activation and inducing apoptosis.
    Che SM; Zhang XZ; Hou L; Song TB
    Cancer Invest; 2010 Aug; 28(7):679-88. PubMed ID: 20486853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
    Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J
    J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R.
    Su H; Jin X; Zhang X; Zhao L; Lin B; Li L; Fei Z; Shen L; Fang Y; Pan H; Xie C
    J Transl Med; 2015 Mar; 13():104. PubMed ID: 25888911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
    Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T
    Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells.
    Kase S; Osaki M; Honjo S; Takeda A; Adachi K; Araki K; Ito H
    J Exp Clin Cancer Res; 2004 Jun; 23(2):301-7. PubMed ID: 15354416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
    Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
    Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1.
    Du Y; Zhang S; Wang Z; Zhou W; Luan M; Yang X; Chen N
    Oncol Rep; 2008 Sep; 20(3):605-11. PubMed ID: 18695912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
    Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
    Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [NS398 induced apoptosis in pancreatic carcinoma cell strain BxPC-3 through a COX-2-in dependent pathway].
    Huang DS; Xu X; Zheng SS; Cheng JF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):601-5. PubMed ID: 16274041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiobiological characteristics of cancer stem cells from esophageal cancer cell lines.
    Wang JL; Yu JP; Sun ZQ; Sun SP
    World J Gastroenterol; 2014 Dec; 20(48):18296-305. PubMed ID: 25561796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
    Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
    Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus.
    Zhang X; Komaki R; Wang L; Fang B; Chang JY
    Clin Cancer Res; 2008 May; 14(9):2813-23. PubMed ID: 18451249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.
    Liu XH; Yao S; Kirschenbaum A; Levine AC
    Cancer Res; 1998 Oct; 58(19):4245-9. PubMed ID: 9766645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells.
    Wang J; Lei ZJ; Guo Y; Wang T; Qin ZY; Xiao HL; Fan LL; Chen DF; Bian XW; Liu J; Wang B
    Oncotarget; 2015 Nov; 6(35):37852-70. PubMed ID: 26497997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parthenolide cooperates with NS398 to inhibit growth of human hepatocellular carcinoma cells through effects on apoptosis and G0-G1 cell cycle arrest.
    Ralstin MC; Gage EA; Yip-Schneider MT; Klein PJ; Wiebke EA; Schmidt CM
    Mol Cancer Res; 2006 Jun; 4(6):387-99. PubMed ID: 16778086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Andrographolide radiosensitizes human esophageal cancer cell line ECA109 to radiation in vitro.
    Wang ZM; Kang YH; Yang X; Wang JF; Zhang Q; Yang BX; Zhao KL; Xu LP; Yang LP; Ma JX; Huang GH; Cai J; Sun XC
    Dis Esophagus; 2016 Jan; 29(1):54-61. PubMed ID: 25059546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitory effect of NS398 on the proliferation of human ovarian cancer cell lines CAOV3 and OVCAR3 in vitro].
    Wang CY; Wang M; Wang XY; Zhang SL; Wang YX; Li LK
    Zhonghua Fu Chan Ke Za Zhi; 2003 Jul; 38(7):415-8. PubMed ID: 12921553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
    Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
    Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF
    Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.